DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy

dc.contributor.authorGraf, Franziska
dc.contributor.authorFahrer, Jörg
dc.contributor.authorMaus, Stephan
dc.contributor.authorMorgenstern, Alfred
dc.contributor.authorBruchertseifer, Frank
dc.contributor.authorVenkatachalam, Senthil
dc.contributor.authorFottner, Christian
dc.contributor.authorWeber, Matthias M.
dc.contributor.authorHuelsenbeck, Johannes
dc.contributor.authorSchreckenberger, Mathias
dc.contributor.authorKaina, Bernd
dc.contributor.authorMiederer, Matthias
dc.date.accessioned2022-10-13T09:21:22Z
dc.date.available2022-10-13T09:21:22Z
dc.date.issued2014
dc.description.abstractRationale Key biologic effects of the alpha-particle emitter Actinium-225 in comparison to the beta-particle emitter Lutetium-177 labeled somatostatin-analogue DOTATOC in vitro and in vivo were studied to evaluate the significance of γH2AX-foci formation. Methods To determine the relative biological effectiveness (RBE) between the two isotopes (as - biological consequence of different ionisation-densities along a particle-track), somatostatin expressing AR42J cells were incubated with Ac-225-DOTATOC and Lu-177-DOTATOC up to 48 h and viability was analyzed using the MTT assay. DNA double strand breaks (DSB) were quantified by immunofluorescence staining of γH2AX-foci. Cell cycle was analyzed by flow cytometry. In vivo uptake of both radiolabeled somatostatin-analogues into subcutaneously growing AR42J tumors and the number of cells displaying γH2AX-foci were measured. Therapeutic efficacy was assayed by monitoring tumor growth after treatment with activities estimated from in vitro cytotoxicity. Results Ac-225-DOTATOC resulted in ED50 values of 14 kBq/ml after 48 h, whereas Lu-177-DOTATOC displayed ED50 values of 10 MBq/ml. The number of DSB grew with increasing concentration of Ac-225-DOTATOC and similarly with Lu-177-DOTATOC when applying a factor of 700-fold higher activity compared to Ac-225. Already 24 h after incubation with 2.5–10 kBq/ml, Ac-225-DOTATOC cell-cycle studies showed up to a 60% increase in the percentage of tumor cells in G2/M phase. After 72 h an apoptotic subG1 peak was also detectable. Tumor uptake for both radio peptides at 48 h was identical (7.5%ID/g), though the overall number of cells with γH2AX-foci was higher in tumors treated with 48 kBq Ac-225-DOTATOC compared to tumors treated with 30 MBq Lu-177-DOTATOC (35% vs. 21%). Tumors with a volume of 0.34 ml reached delayed exponential tumor growth after 25 days (44 kBq Ac-225-DOTATOC) and after 21 days (34 MBq Lu-177-DOTATOC). Conclusion γH2AX-foci formation, triggered by beta- and alpha-irradiation, is an early key parameter in predicting response to internal radiotherapy.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.identifier.doihttp://doi.org/10.25358/openscience-7977
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7992
dc.language.isoengde
dc.rightsCC-BY-4.0*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleDNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapyen_GB
dc.typeZeitschriftenaufsatzde
jgu.identifier.pmid24516620
jgu.journal.issue2de
jgu.journal.titlePLoS onede
jgu.journal.volume9de
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.nameJohannes Gutenberg-Universität Mainz
jgu.organisation.number2700
jgu.organisation.placeMainz
jgu.organisation.rorhttps://ror.org/023b0x485
jgu.pages.alternativee88239de
jgu.publisher.doi10.1371/journal.pone.0088239de
jgu.publisher.issn1932-6203de
jgu.publisher.namePLoSde
jgu.publisher.placeLawrence, Kan.de
jgu.publisher.urihttp://dx.doi.org/10.1371/journal.pone.0088239de
jgu.publisher.year2014
jgu.rights.accessrightsopenAccess
jgu.subject.ddccode610de
jgu.type.dinitypeArticleen_GB
jgu.type.resourceTextde
jgu.type.versionPublished versionde
opus.affiliatedFahrer, Jörg
opus.affiliatedFottner, Christian
opus.affiliatedWeber, Matthias M.
opus.affiliatedSchreckenberger, Mathias
opus.affiliatedKaina, Bernd
opus.affiliatedMiederer, Matthias
opus.date.modified2018-08-08T08:15:15Z
opus.identifier.opusid27325
opus.importsourcepubmed
opus.institute.number0414
opus.institute.number0422
opus.institute.number0425
opus.metadataonlyfalse
opus.organisation.stringFB 04: Medizin: Institut für Toxikologiede_DE
opus.organisation.stringFB 04: Medizin: Klinik und Poliklinik für Nuklearmedizinde_DE
opus.organisation.stringFB 04: Medizin: I. Medizinische Klinik und Poliklinikde_DE
opus.subject.dfgcode00-000
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
dna_double_strand_breaks_as_p-20220925155731505.pdf
Size:
3.22 MB
Format:
Adobe Portable Document Format
Description: